178 related articles for article (PubMed ID: 22961429)
1. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
[TBL] [Abstract][Full Text] [Related]
2. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
[TBL] [Abstract][Full Text] [Related]
3. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
[TBL] [Abstract][Full Text] [Related]
4. Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
Schulte JJ; Steinmetz J; Furtado LV; Husain AN; Lingen MW; Cipriani NA
Head Neck Pathol; 2020 Dec; 14(4):966-973. PubMed ID: 32350806
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.
Schache AG; Liloglou T; Risk JM; Filia A; Jones TM; Sheard J; Woolgar JA; Helliwell TR; Triantafyllou A; Robinson M; Sloan P; Harvey-Woodworth C; Sisson D; Shaw RJ
Clin Cancer Res; 2011 Oct; 17(19):6262-71. PubMed ID: 21969383
[TBL] [Abstract][Full Text] [Related]
6. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
[TBL] [Abstract][Full Text] [Related]
7. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma.
Gheit T; Abedi-Ardekani B; Carreira C; Missad CG; Tommasino M; Torrente MC
J Med Virol; 2014 Apr; 86(4):642-6. PubMed ID: 24374907
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.
Jouhi L; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Hagström J
Cancer Immunol Immunother; 2017 Dec; 66(12):1619-1629. PubMed ID: 28856441
[TBL] [Abstract][Full Text] [Related]
10. Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma.
Lewis JS; Naegele S; Efthymiou V; Mehrad M; Ely KA; Waterboer T; Lang Kuhs KA; Davis SJ; Richard K; Das D; Faden DL
Am J Clin Pathol; 2024 Jun; 161(6):570-578. PubMed ID: 38349613
[TBL] [Abstract][Full Text] [Related]
11. Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.
Al-Taei S; Banner R; Powell N; Evans M; Palaniappan N; Tabi Z; Man S
Cancer Immunol Immunother; 2013 Dec; 62(12):1821-30. PubMed ID: 24146146
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation.
Qian G; Wang D; Magliocca KR; Hu Z; Nannapaneni S; Kim S; Chen Z; Sun SY; Shin DM; Saba NF; Chen ZG
Eur J Cancer; 2016 Sep; 65():21-32. PubMed ID: 27451021
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
Tian Q; Huang J; Zhang Q; Zhao J
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
[TBL] [Abstract][Full Text] [Related]
15. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.
Park JW; Shin MK; Lambert PF
Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an E6/E7 PCR-capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer.
Yin J; Li Y; Song C; Liu Y; Zhao J; Zhao D; Zhang S; Zhang X; Zhao F; Qiao Y
J Med Virol; 2024 Jun; 96(6):e29716. PubMed ID: 38818787
[TBL] [Abstract][Full Text] [Related]
17. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.
Halec G; Holzinger D; Schmitt M; Flechtenmacher C; Dyckhoff G; Lloveras B; Höfler D; Bosch FX; Pawlita M
Br J Cancer; 2013 Jul; 109(1):172-83. PubMed ID: 23778529
[TBL] [Abstract][Full Text] [Related]
18. Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
Deutsch F; Sais D; Keatinge N; Hill M; Tran NH; Elliott M; Tran N
BMC Cancer; 2024 Apr; 24(1):442. PubMed ID: 38600473
[TBL] [Abstract][Full Text] [Related]
19. Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma.
Anayannis NV; Schlecht NF; Ben-Dayan M; Smith RV; Belbin TJ; Ow TJ; Blakaj DM; Burk RD; Leonard SM; Woodman CB; Parish JL; Prystowsky MB
PLoS One; 2018; 13(2):e0191581. PubMed ID: 29451891
[TBL] [Abstract][Full Text] [Related]
20. Tissue Fixation Conditions for p16 Immunohistochemistry and Human Papillomavirus RNA In Situ Hybridization in Oropharyngeal Squamous Cell Carcinoma.
Lewis JS; Barnett SB; Mannion K; Mehrad M
Head Neck Pathol; 2020 Sep; 14(3):637-644. PubMed ID: 31628584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
